The v‐raf murine sarcoma viral oncogene homolog B1 (BRAF) gene has been found to function as a driver oncogene through mitogen‐activated protein kinase (MAPK) signaling1 in patients with non‐small cell lung cancer (NSCLC). This evidence concerns the gene BRAF and non-small cell lung carcinoma.